BioLife Solutions (United States)
- Research works
- 36 ▼ 6% vs 2013–17
- Citations
- 607 17.0 per fractional work
- Top-10% rate
- 17.3% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: BioLife Solutions (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.4×. Every wedge is a field page.
Which keywords describe research at BioLife Solutions (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Regenerative Medicine, Fertility Preservation, Ovarian Tissue Cryopreservation, Differentiation, Pluripotent Stem Cells, Stem Cell Therapy, Transcriptional Regulation and Extracellular Matrix.
- Regeneration
- Immunotherapy
- Fiber Networks
- Mesenchymal Stem Cells
- Cardiovascular Disease
- Cancer
- Tissue Engineering
- Organ Engineering
- Embryonic Stem Cells
- Transcriptional Regulation
- Extracellular Matrix
- Differentiation
- Fertility Preservation
- Regenerative Medicine
- Ovarian Tissue Cryopreservation
- Pluripotent Stem Cells
- Stem Cell Therapy
- Decellularization
- Induced Pluripotent Stem Cells
- Epidemiology
- Cell Culture
- Oxidative Stress
- Hydrogels
- Nanoparticles
- Hypertension
- Paper Mechanics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Regenerative Medicine4▲ 54×6 topics
- Fertility Preservation4▲ 155×1 topic
- Ovarian Tissue Cryopreservation4▲ 155×1 topic
- Differentiation3▲ 114×2 topics
- Pluripotent Stem Cells2▲ 101×2 topics
- Extracellular Matrix2▲ 28×2 topics
- Stem Cell Therapy2▲ 71×2 topics
- Transcriptional Regulation2▲ 27×2 topics
- Decellularization2▲ 170×1 topic
- Embryonic Stem Cells2▲ 88×1 topic
- Induced Pluripotent Stem Cells2▲ 186×1 topic
- Organ Engineering2▲ 170×1 topic
- Epidemiology2▲ 1.25×7 topics
- Tissue Engineering2▲ 9.5×5 topics
- Cell Culture2▲ 44×3 topics
- Cancer2▲ 3.0×10 topics
- Oxidative Stress1▲ 1.85×7 topics
- Cardiovascular Disease1▲ 2.7×4 topics
- Hydrogels1▲ 22×2 topics
- Mesenchymal Stem Cells1▲ 25×2 topics
- Nanoparticles1▲ 2.4×5 topics
- Fiber Networks1▲ 144×1 topic
- Hypertension1▲ 8.0×4 topics
- Immunotherapy1▲ 4.3×3 topics
- Paper Mechanics1▲ 144×1 topic
- Regeneration1▲ 16×3 topics
Which research topics does BioLife Solutions (United States) publish most on?
By volume in 2022–2025: Material Properties and Processing, Tissue Engineering and Regenerative Medicine, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Material Properties and Processing Mechanics of Materials 1 works
- 2 Tissue Engineering and Regenerative Medicine Surgery 1 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 5 Reproductive biology and impacts on aquatic species Physiology 0 works
- 6 RNA Research and Splicing Molecular Biology 0 works
- 7 Physiological and biochemical adaptations Ecology 0 works
- 8 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
- 9 Protein purification and stability Molecular Biology 0 works
- 10 Amino Acid Enzymes and Metabolism Biochemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has BioLife Solutions (United States)'s research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bothell
- University of Washington Bothell
- Modern Electron (United States)
- Radar (United States)
- Seagen (United States)
- EKOS Corporation
- Epoch Biosciences (United States)
- OncoGenex Pharmaceuticals (United States)
- Sonic Concepts (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.